Financhill
Buy
75

TSCDY Quote, Financials, Valuation and Earnings

Last price:
$14.05
Seasonality move :
0.77%
Day range:
$13.88 - $14.11
52-week range:
$10.36 - $14.85
Dividend yield:
3.36%
P/E ratio:
19.49x
P/S ratio:
0.37x
P/B ratio:
2.07x
Volume:
300.2K
Avg. volume:
289K
1-year change:
27.84%
Market cap:
$31.4B
Revenue:
$85.4B
EPS (TTM):
$0.63
Period Ending 2020-02-29 2021-03-01 2022-03-01 2023-03-01 2024-02-29
Revenue $74.3B -- -- -- $85.4B
Revenue Growth (YoY) -11.94% -- -- -- 7.51%
 
Cost of Revenues $69B -- -- -- $79.3B
Gross Profit $5.2B -- -- -- $6.1B
Gross Profit Margin 7.05% -- -- -- 7.11%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.2B -- -- -- $2.5B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.3B -- -- -- $2.6B
Operating Income $2.9B -- -- -- $3.4B
 
Net Interest Expenses $988.1M -- -- -- $698.7M
EBT. Incl. Unusual Items $1.3B -- -- -- $2.9B
Earnings of Discontinued Ops. $300.4M -- -- -- -$716.2M
Income Tax Expense $370.7M -- -- -- $657.4M
Net Income to Company $3.2B -- -- -- $2.7B
 
Minority Interest in Earnings -$2.6M -- -- -- -$5M
Net Income to Common Excl Extra Items $1.2B -- -- -- $1.5B
 
Basic EPS (Cont. Ops) $0.49 -- -- -- $0.63
Diluted EPS (Cont. Ops) $0.48 -- -- -- $0.62
Weighted Average Basic Share $2.6B -- -- -- $2.4B
Weighted Average Diluted Share $2.6B -- -- -- $2.4B
 
EBITDA $5B -- -- -- $6B
EBIT $2.2B -- -- -- $3.9B
 
Revenue (Reported) $74.3B -- -- -- $85.4B
Operating Income (Reported) $2.9B -- -- -- $3.4B
Operating Income (Adjusted) $2.2B -- -- -- $3.9B
Period Ending 2010-02-28 2011-02-28 2012-02-28 2013-02-28 2014-02-28
Revenue -- -- -- -- --
Revenue Growth (YoY) 9.31% 12.55% -- -0.22% 4%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-08-31 2021-08-31 2022-08-31 2023-08-31 2024-08-31
Revenue $75.3B $81.9B $81B $83B $88.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $70B $76.1B $76B $77.8B $81.7B
Gross Profit $5.3B $5.8B $5B $5.2B $6.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.3B $2.6B $2.5B $2.4B $2.6B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.4B $2.7B $2.6B $2.5B $2.7B
Operating Income $2.9B $3.1B $2.3B $2.7B $3.8B
 
Net Interest Expenses $961.1M $903.4M $715.4M $756.9M $695.4M
EBT. Incl. Unusual Items $1.5B $1.7B $1.7B $2.1B $3.2B
Earnings of Discontinued Ops. $355.8M $7.2B $3.6M $157M -$740.7M
Income Tax Expense $401.7M $365.9M $439.4M $446.4M $793.1M
Net Income to Company $3.2B $9.8B $2.6B $2.9B $3B
 
Minority Interest in Earnings -$9M $1.4M -$8.7M $4.8M -$2.5M
Net Income to Common Excl Extra Items $1.4B $8.6B $1.2B $1.8B $1.7B
 
Basic EPS (Cont. Ops) $0.56 $2.71 $0.49 $0.74 $0.73
Diluted EPS (Cont. Ops) $0.56 $2.70 $0.48 $0.73 $0.72
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $5B $5B $4.7B $5.1B $6.5B
EBIT $2.4B $2.6B $2.5B $3B $4.2B
 
Revenue (Reported) $75.3B $81.9B $81B $83B $88.2B
Operating Income (Reported) $2.9B $3.1B $2.3B $2.7B $3.8B
Operating Income (Adjusted) $2.4B $2.6B $2.5B $3B $4.2B
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-02-29 2021-03-01 2022-03-01 2023-03-01 2024-02-29
Cash and Equivalents $5.3B -- -- -- $2.9B
Short Term Investments $1.6B -- -- -- $3B
Accounts Receivable, Net $1.8B -- -- -- $1.7B
Inventory $3.1B -- -- -- $3.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $17.8B -- -- -- $21B
 
Property Plant And Equipment $33.4B -- -- -- $28.7B
Long-Term Investments -- -- -- -- --
Goodwill $6.2B -- -- -- $5.2B
Other Intangibles $1.6B -- -- -- $1.2B
Other Long-Term Assets -- -- -- -- --
Total Assets $68B -- -- -- $59.5B
 
Accounts Payable $11.4B -- -- -- $13B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $766.5M -- -- -- $739.3M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $23.9B -- -- -- $25.9B
 
Long-Term Debt $7.7B -- -- -- $7.2B
Capital Leases -- -- -- -- --
Total Liabilities $51B -- -- -- $44.8B
 
Common Stock $628.1M -- -- -- $563.3M
Other Common Equity Adj -- -- -- -- --
Common Equity $17.1B -- -- -- $14.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$28.2M -- -- -- -$7.6M
Total Equity $17B -- -- -- $14.8B
 
Total Liabilities and Equity $68B -- -- -- $59.5B
Cash and Short Terms $6.9B -- -- -- $5.9B
Total Debt $10.5B -- -- -- $9.1B
Period Ending 2020-08-31 2021-08-31 2022-08-31 2023-08-31 2024-08-31
Cash and Equivalents $4.3B $2.9B $2.7B $3.2B $4.3B
Short Term Investments $1.3B $3.7B $2.8B $3.8B $2.7B
Accounts Receivable, Net $1.9B $1.6B $1.6B $1.6B $1.7B
Inventory $3B $3.1B $3B $3.6B $3.9B
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $71.5M $67.6M -- --
Total Current Assets $22.7B $16.7B $15.5B $17.8B $23.4B
 
Property Plant And Equipment $30.3B $31.1B $25.6B $28.4B $29.6B
Long-Term Investments -- -- -- -- --
Goodwill $6.1B $5.9B $5B -- --
Other Intangibles $1.6B $1.5B $1.2B -- --
Other Long-Term Assets -- $282M $201.7M -- --
Total Assets $69.6B $64.8B $55.4B $60.5B $62.4B
 
Accounts Payable $11.1B $12.2B $11.4B $13.5B $14.3B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $743.9M $766.3M $688.9M $753.7M $796.9M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $24.6B $22B $19.7B $24.1B $28.9B
 
Long-Term Debt $8.7B $8.4B $7.6B $7.5B $7.3B
Capital Leases -- -- -- -- --
Total Liabilities $53.4B $46.4B $39.5B $45.2B $47.2B
 
Common Stock $654.4M $674.1M $552.5M $573.2M $568.5M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$22.7M -$24.8M -$12.8M -$8.9M -$7.9M
Total Equity $16.3B $18.3B $15.9B $15.3B $15.2B
 
Total Liabilities and Equity $69.6B $64.8B $55.4B $60.5B $62.4B
Cash and Short Terms $5.6B $6.6B $5.6B $7B $7B
Total Debt $10.4B $10.1B $8.8B $10.1B $9.3B
Period Ending 2020-02-29 2021-03-01 2022-03-01 2023-03-01 2024-02-29
Net Income to Stockholders $3.2B -- -- -- $2.7B
Depreciation & Amoritzation $2.8B -- -- -- $2.2B
Stock-Based Compensation $111.2M -- -- -- $97.7M
Change in Accounts Receivable $782.3M -- -- -- -$1.1B
Change in Inventories $228.8M -- -- -- -$187.8M
Cash From Operations $61.4M -- -- -- $4.8B
 
Capital Expenditures $1.5B -- -- -- $1.7B
Cash Acquisitions $334.9M -- -- -- -$2.5M
Cash From Investing $3.1B -- -- -- -$2.1B
 
Dividends Paid (Ex Special Dividend) -$838.5M -- -- -- -$974.2M
Special Dividend Paid
Long-Term Debt Issued $1.6B -- -- -- $1.5B
Long-Term Debt Repaid -$2.2B -- -- -- -$970.4M
Repurchase of Common Stock -$190.5M -- -- -- -$1.1B
Other Financing Activities -$21.7M -- -- -- -$82.6M
Cash From Financing -$2.5B -- -- -- -$2.3B
 
Beginning Cash (CF) $3.3B -- -- -- $2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $646.8M -- -- -- $350.6M
Ending Cash (CF) $3.9B -- -- -- $1.9B
 
Levered Free Cash Flow -$1.5B -- -- -- $3.1B
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-08-31 2021-08-31 2022-08-31 2023-08-31 2024-08-31
Net Income to Stockholders $3.2B $9.8B $2.6B $2.9B $3B
Depreciation & Amoritzation $2.6B $2.4B $2.2B $2.1B $2.2B
Stock-Based Compensation $106.6M $56.5M $69.6M $72.5M $106.8M
Change in Accounts Receivable $848.9M $2.8B -$720.9M -$754.7M -$940.4M
Change in Inventories $93.6M -$50.1M -$464.8M -$345.7M -$150M
Cash From Operations $393.5M $1.5B $4.4B $5.3B $4.6B
 
Capital Expenditures $1.7B $1.8B $1.5B $1.7B $1.7B
Cash Acquisitions $313.9M $9.8B -$43.3M $7.9M -$82M
Cash From Investing $3.3B $6.4B -$711.5M -$2.2B $469.7M
 
Dividends Paid (Ex Special Dividend) -$1.1B -$7.8B -$1B -$989.2M -$1.1B
Special Dividend Paid
Long-Term Debt Issued $1.1B -- -- $1.3B $755.9M
Long-Term Debt Repaid -$822.2M -$2.1B -$1B -$951.1M -$1.7B
Repurchase of Common Stock -$227.5M -$58.6M -$993.6M -$1.2B -$1.2B
Other Financing Activities -$363.1M -$539.2M -$349M $26M -$41.5M
Cash From Financing -$2.3B -$10.5B -$3.6B -$2.6B -$4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $859.9M -$1.7B $59.9M $350.2M $687.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$1.3B -$240.6M $3B $3.6B $2.8B
Period Ending 2021-12-23 2022-12-23 2023-12-23 2024-12-23 2025-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock